Joshua Lang, MD, MS

Financial relationships

  • Attribution: 
    Self
    Ineligible company: 
    Salus Discovery, LLC
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/25/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    4D Pharma
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/25/2022
Return to The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion: A Virtual Course (2022)